15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 9.5% per year over the past 5 years.
Operating margin has expanded, at -12.8% in the latest year.
Financial health
Total debt ($17M) exceeds cash ($3M); net debt is $14M.
Total debt has grown faster than revenue (27.8% vs 9.5% per year).
Operating income covered interest expense -2.3× in the latest year, up from -9.0× 5 years ago.
Total debt is 8.2× EBITDA.
The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$28M
-$2M
18.0%
-12.8%
-$5M
$17M
$3M
2024
$28M
$2M
32.4%
-9.9%
-$8M
$20M
$11M
2023
$21M
$610000
43.8%
1.3%
-$555000
$13M
$14M
2022
$20M
$1M
42.4%
12.3%
$7M
$14M
$12M
2021
$18M
$194000
38.2%
7.7%
$5M
$16M
$8M
2020
$18M
-$7M
25.0%
-53.1%
$9M
$5M
$4M
2019
$21M
$659000
33.6%
7.5%
$7M
$3M
$1M
2018
$20M
$1M
38.0%
9.4%
$6M
$5M
$1M
2017
$20M
$2M
44.3%
12.3%
$7M
$6M
$2M
2016
—
$930000
—
—
$7M
$7M
$3M
2015
—
-$2M
—
—
$8M
$10M
$2M
2014
—
-$952000
—
—
—
$11M
$1M
2013
—
-$312000
—
—
$6M
$16M
$2M
2012
—
$38000
—
—
$235000
$18M
$2M
2011
—
$506000
—
—
$1M
$15M
$3M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$7M
-$612000
18.2%
-13.0%
$2M
$17M
$5M
Dec '25
$8M
-$631000
11.7%
-18.1%
$1M
$17M
$3M
Sep '25
$7M
-$17000
22.1%
-4.8%
-$2M
$18M
$5M
Jun '25
$7M
-$280000
23.1%
-7.7%
-$2M
$19M
$11M
Mar '25
$6M
-$625000
15.4%
-21.3%
-$2M
$20M
$11M
Dec '24
$9M
-$1M
35.3%
-20.2%
-$4M
$20M
$11M
Sep '24
$7M
-$207000
19.6%
-12.7%
-$407000
$14M
$14M
Jun '24
$7M
$4M
35.0%
-0.0%
$70000
$15M
$14M
Mar '24
$5M
$119000
41.1%
-1.6%
-$3M
$16M
$13M
Dec '23
$6M
$415000
49.4%
7.1%
-$3M
$13M
$14M
Sep '23
$5M
$118000
40.9%
1.8%
-$51000
$12M
$15M
Jun '23
$6M
-$111000
45.2%
-5.8%
$1M
$12M
$14M
Mar '23
$5M
$188000
38.7%
2.0%
$2M
$13M
$13M
Dec '22
$5M
$246000
45.1%
11.7%
$2M
$14M
$12M
Sep '22
$5M
$316000
40.5%
9.3%
$1M
$14M
$12M
Jun '22
$5M
$497000
41.5%
15.8%
$4M
$15M
$12M
Mar '22
$5M
$269000
42.6%
12.4%
$193000
$15M
$8M
Dec '21
$5M
$219000
47.3%
15.4%
$2M
$16M
$8M
Sep '21
$4M
$33000
35.8%
4.5%
-$802000
$16M
$7M
Jun '21
$4M
-$87000
35.9%
7.9%
$2M
$16M
$8M
Valuation over time
How the market has priced AMS against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 14.2× (Mar '23) to 6.5× (Nov '25).
The price-to-sales ratio has fallen from 1.0× (Mar '23) to 0.4× (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is AMS growing its revenue and profit?
Over the past 5 years, AMERICAN SHARED HOSPITAL SERVICES's revenue has grown 9.5% per year. These are computed facts, not advice.
How much debt does AMS have?
As of FY2025, AMERICAN SHARED HOSPITAL SERVICES reported $17M of total debt against $3M of cash; operating income covered interest expense -2.3×.
What is AMS's profit margin?
In FY2025, gross margin was 18.0%, operating margin -12.8%, and net margin -5.5%.
What is AMS's P/E ratio?
As of Jun '26, AMERICAN SHARED HOSPITAL SERVICES traded at a price-to-earnings ratio of about 6.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.